a Refacto tool
AdvertisementYour banner here · 728 × 90 · ads@refacto.app

← Explore · Market KXFDAAPPROVE-MDMA-31JAN01

Will the FDA approve midomafetamine / MDMA for PTSD before Jan 1, 2031?

54.0% implied · bid 52.0¢ · ask 56.0¢

☆ Log in to track

A · Price & probability

The market prices this at 53.0%, down 1.0pt over 24h, on a 4.0¢ spread.

Implied probability53.0%
Bid / ask / mid52.0¢ / 56.0¢ / 54.0¢
Spread4.0¢ (7.4%)
Change 24h-1.00pt
Change 7d+0.50pt

B · Liquidity & flow

Thin (score 30/100) — trade small; large orders will move the price. Order book leans 15% to the ask (sellers).

Volume 24h$0
Depth ±5¢ (bid/ask)$24 / $280
Imbalance15% bid
Large trades (>$1k)0
Liquidity score30.2 / 100

C · Momentum & volatility

RSI 49 (neutral); price is below its 7-day mean by 0.4σ — normal range.

Z-score vs 7d mean-0.40
RSI (14, hourly)49.3
Realized vol 7d4.16pt
Change 1h+0.00pt

E · Time & structure

Resolves in 1945d 7h.

Time to resolve1945d 7h
Resolution sourcemanual-review
Sum of outcomes100.0%

Price history

Probability timeline

Order-book depth